<DOC>
	<DOC>NCT00350636</DOC>
	<brief_summary>A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.</brief_summary>
	<brief_title>A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Females and males, 18 years of older with overactive bladder symptoms Treatable conditions that may cause urinary incontinence Medical conditions in which it would be unsafe to use an anticholinergic agent. The use of concomitant drugs that would confound the efficacy evaluation. The use of concomitant drugs that would be unsafe with an anticholinergic agent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>OAB, anticholineric, oxybutynin, urge urinary incontinence</keyword>
</DOC>